• Center on Health Equity & Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

Authors


H. Shelton Brown III, PhD

Latest:

Diabetes and Employment Productivity: Does Diabetes Management Matter?

Diabetes itself affected working and wages more than control of blood sugar levels in a Mexican American population.




Bibiana Martinez, MPH

Latest:

Preventing Patient Absenteeism: Validation of a Predictive Overbooking Model

Electronic health record data can be used to predict patient absenteeism accurately. Predictive overbooking of missed appointments can significantly increase service utilization.


Andrew O. Westfall, MS

Latest:

Implications of DRG Classification in a Bundled Payment Initiative for COPD

Diagnosis-related group coding determines eligibility for many Medicare bundled payment initiatives. This approach excluded many patients with chronic obstructive pulmonary disease likely to benefit while including others without the disease.




Ryan J. Boe, MHPA

Latest:

Implementation of Paperless Credentialing in a Multi-State Managed Care Organization

Institution of paperless credentialing is analyzed on a pre-/post-implementation basis to understand the impact on business and productivity.


Susan R. Snyder, PhD

Latest:

The Value of Value-Based Insurance Design: Savings From Eliminating Drug Co-Payments

Geisinger Health System’s $0 co-pay drug program for its chronically ill employee population is associated with positive cost savings and a 5-year return-on-investment of approximately 1.8.



David T. Grande, MD, MPA

Latest:

Economic Outcomes of Insurer-Led Care Management for High-Cost Medicaid Patients

This study evaluated economic outcomes of an insurer-led care management program for high-cost Medicaid patients using teams of community health care workers and nurses.




Mark A. Drew, BID

Latest:

Face Time Versus Test Ordering: Is There a Trade-off?

Real-time location systems can capture face time and trade-offs between face time and diagnostic testing so that clinicians' responses to time pressures can be measured.


Fabian Camacho, MS

Latest:

Persistent High Utilization in a Privately Insured Population

This study describes the small number of individuals responsible for larger shares of healthcare cost persistently over a 3-year period.






Alan Oglesby, MPH

Latest:

Clinical Characteristics and Treatment Patterns Among US Patients With HIV

It is important to take into account individual complexities such as comorbidities and pill burden when selecting antiretroviral therapy regimens for individuals living with HIV.


Lynda C. Burton, ScD

Latest:

Substitutive Hospital at Home for Older Persons: Effects on Costs

Substitutive Hospital at Home care for 4 common conditions is associated with cost savings.


R. Wayne Fuqua, PhD

Latest:

Using Simulation to Identify and Resolve Threats to Patient Safety

The same simulation methodology used in the aviation industry was able to uncover latent environmental threats to patient safety.



Joseph Antos, PhD

Latest:

Availability of Prices for Shoppable Services on Hospital Internet Sites

Only 60% of hospitals display their cash prices and 5% display their minimum negotiated charges on their public websites; many hospitals are in violation of new federal legislation.


Hsueh-Fen Chen, PhD

Latest:

Geographic Variation in Medicare Home Health Expenditures

This study attempts to identify the sources of the significant 2.5-fold variation found in home health expenditures, a possible indicator of inefficiency and waste.



Hilary Campbell, PharmD, JD

Latest:

Value-Based Arrangements May Be More Prevalent Than Assumed

We surveyed biopharmaceutical manufacturers and payers to understand the prevalence and characteristics of value-based payment arrangements, as well as their implementation obstacles and success factors.


Robert J. Nordyke, MS, PhD

Latest:

US Payer Perspectives on Evidence for Formulary Decision Making

To improve formulary design processes and support payers in providing more effective healthcare, policy makers should consider involving commercial payers in the development of comparative effectiveness research and creation of research and treatment guidelines.



© 2024 MJH Life Sciences
AJMC®
All rights reserved.